Home
Our Pipeline
Clinical Trials
CB-24 Mode of Action
Scientific Reviews
Media
The Team
Contact Us

Investor Relations

Reach Us



Our Office

38/39 Fitzwilliam Square West Dublin 2, D02 NX53 Ireland.



Email

Please Provide Email



Phone

Please Provide Phone

A clinical-stage biopharmaceutical company developing first-in-class venom-derived peptide therapies to transform patient outcomes.

Follow
Follow

COMPANY

Our Pipeline

Clinical Trials

CB-24 Mode of Action

Scientific Reviews

Media

The Team

INVESTORS

Overview

Press Releases

Financial Reports

Events

Governance

CONTACT

Investor Relations

Get in Touch

Media Inquiries

Privacy Policy

© 2026 Celtic Biotech. All rights reserved.